Cerevel Therapeutics Holdings logo
Cerevel Therapeutics Holdings CERE
$ 44.96 0.0%

Quarterly report 2024-Q1
added 05-08-2024

report update icon

Cerevel Therapeutics Holdings Operating Expenses 2011-2024 | CERE

Annual Operating Expenses Cerevel Therapeutics Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
447 M 368 M 220 M 149 M - - - - 30.9 M 31.7 M 37.8 M 31.8 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
447 M 30.9 M 165 M

Quarterly Operating Expenses Cerevel Therapeutics Holdings

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
143 M - 111 M 96.8 M 99.6 M - 95.1 M 93 M 72.5 M - 54.5 M 50.5 M 50.6 M - 34.4 M 35.2 M 37.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
143 M 34.4 M 74.9 M